Colin Broom M.D., Chief Executive Officer at Nabriva Therapeutics plc (NBRV), bought 2,588 shares at $8.35 ($22K) on 2017-09-22, disclosed to the SEC on 2017-09-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NBRV | SELL | 2020-08-21 | $7K | — | Filing → |
| NBRV | BUY | 2019-09-03 | $21K | — | Filing → |
| NBRV | BUY | 2018-06-25 | $19K | — | Filing → |